Search AAWH
Ascend Wellness Holdings, Inc.
OTC Markets OTCQX · CIK 1756390
Last close0.56
Daily change+0.05 (10.78%)
10 Years gain-94.21%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
AAWH · STANDARD
SIC 2833 · Medicinal Chemicals & Botanical Products · Fiscal year end 1231
Fundamental
36.1Momentum
54.5Acceleration
54.5Confidence
85.0Annual Revenue7
Quarterly Revenue24
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth10.4 / 25
Quality14.2 / 25
Capital Efficiency4.1 / 20
Balance Sheet7.5 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 3.466 percentage points.
Operating leverageOperating margin improved by 0.908 percentage points.
Share count reductionDiluted share count declined 0.9688%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM-10.57%OK
Revenue CAGR 3Y7.24%OK
Gross Margin35.42%OK
Operating Margin1.11%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC6.52%OK
Incremental Operating Margin 3Y12.52%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-0.97%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $500.58M | $169.68M | -$17.01M | $38.05M | $12.04M | 33.9% | -3.4% | 2.41% | -5.63% | 203.48M |
| 2025 FY Dec 31, 2024 | $561.60M | $184.21M | $4.73M | $73.29M | $50.76M | 32.8% | 0.84% | 9.04% | 2.07% | 212.43M |
| 2025 FY Dec 31, 2023 | $518.59M | $155.12M | -$3.62M | $75.33M | $51.09M | 29.91% | -0.7% | 9.85% | -3.58% | 199.15M |
| 2024 FY Dec 31, 2022 | $405.93M | $134.56M | -$7.53M | -$38.36M | -$120.00M | 33.15% | -1.85% | -29.56% | -8.6% | 183.38M |
| 2023 FY Dec 31, 2021 | $332.38M | $135.97M | -$17.20M | -$41.74M | -$130.17M | 40.91% | -5.18% | -39.16% | -13.08% | 149.43M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $495.09M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-056352, 0001628280-25-051164 |
| Revenue Growth TTM | -10.57% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-056352, 0001628280-25-051164 |
| Revenue CAGR 3Y | 7.24% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-017374 |
| Revenue CAGR 5Y | 28.35% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-017374 |
| Gross Profit CAGR 3Y | 8.04% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-017374 |
| Operating Income Growth | 390.11% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-056352, 0001628280-25-051164 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 35.42% | Gross Profit / Revenue | OK | 0001628280-26-056352, 0001628280-25-051164 |
| Operating Margin | 1.11% | Operating Income / Revenue | OK | 0001628280-26-056352, 0001628280-25-051164 |
| ROIC | 6.52% | NOPAT / Average Invested Capital | OK | 0001628280-26-056352, 0001628280-25-051164 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-056352 |
| Current Ratio | 1.66x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.2x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-056352 |
| Revenue per Diluted Share | $2.44 | Revenue / Diluted Shares | OK | 0001628280-26-056352, 0001628280-25-051164 |